The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final clinical outcome and biomarker analysis of sintilimab plus a bevacizumab biosimilar (IBI305) for advanced hepatocellular carcinoma: A phase Ib clinical trial.
 
Wen Zhang
No Relationships to Disclose
 
Caifeng Gong
No Relationships to Disclose
 
Xinyu Bi
No Relationships to Disclose
 
Peng Xuenan
No Relationships to Disclose
 
Yongkun SUN
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Hong Zhao
No Relationships to Disclose
 
Jianqiang Cai
No Relationships to Disclose
 
Ai-Ping Zhou
Consulting or Advisory Role - Novartis; Pfizer